[HTML][HTML] Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
JB Parmera, MCB Oliveira, RD Rodrigues… - Arquivos de Neuro …, 2022 - SciELO Brasil
Background: Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)
are sporadic adult-onset primary tauopathies clinically classified among the atypical …
are sporadic adult-onset primary tauopathies clinically classified among the atypical …
Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration
KA Jellinger - Journal of Neural Transmission, 2023 - Springer
Corticobasal degeneration (CBD) is a rare, sporadic, late-onset progressive
neurodegenerative disorder of unknown etiology, clinically characterized by an akinetic …
neurodegenerative disorder of unknown etiology, clinically characterized by an akinetic …
Nuclear imaging in Parkinson's disease: The past, the present, and the future
H Golan, O Volkov, E Shalom - Journal of the Neurological Sciences, 2022 - Elsevier
The current review analyzed Parkinson's disease-related (PD) literature published from
1817 to 2021 and specifically concentrated on imaging-related works published from the …
1817 to 2021 and specifically concentrated on imaging-related works published from the …
The discourse profile in corticobasal syndrome: a comprehensive clinical and biomarker approach
The aim of this study was to characterize the oral discourse of CBS patients and to verify
whether measures obtained during a semi-spontaneous speech production could …
whether measures obtained during a semi-spontaneous speech production could …
Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6
V Isella, D Licciardo, F Ferri, C Crivellaro… - Frontiers in Aging …, 2022 - frontiersin.org
Background Reduced phonemic fluency is extremely frequent in progressive supranuclear
palsy (PSP), but its neural correlate is yet to be defined. Objective We explored the …
palsy (PSP), but its neural correlate is yet to be defined. Objective We explored the …
Clinical and neuroimaging features of the progressive supranuclear palsy-corticobasal degeneration continuum
JL Whitwell - Current opinion in neurology, 2023 - journals.lww.com
The findings help improve the imaging-based diagnosis of PSP and CBD, allow more
targeted prognostic estimates for patients accounting for phenotype or disease, and will aid …
targeted prognostic estimates for patients accounting for phenotype or disease, and will aid …
Probable 4‐Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG‐PET/MRI Neurodegeneneration Patterns in Corticobasal …
JB Parmera, C de Godoi Carneiro… - Movement Disorders …, 2024 - Wiley Online Library
Background Corticobasal syndrome (CBS) is associated with diverse underlying
pathologies, including the four‐repeat (4R)‐tauopathies. The Movement Disorders Society …
pathologies, including the four‐repeat (4R)‐tauopathies. The Movement Disorders Society …
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease
V Isella, C Crivellaro, A Formenti, M Musarra… - Journal of …, 2022 - Springer
The aim of our study was to establish empirically to what extent reduced glucose uptake in
the precuneus, posterior cingulate and/or temporo-parietal cortex (PCTP), which is thought …
the precuneus, posterior cingulate and/or temporo-parietal cortex (PCTP), which is thought …
Impact of Partial Volume Correction on [18F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome
S Schuster, L Beyer, C Palleis, S Harris, J Schmitt… - Brain Sciences, 2022 - mdpi.com
Corticobasal syndrome (CBS) is a rare neurodegenerative condition characterized by four-
repeat tau aggregation in the cortical and subcortical brain regions and accompanied by …
repeat tau aggregation in the cortical and subcortical brain regions and accompanied by …
[HTML][HTML] Current Opinion of Neurology–Neuroimaging: Clinical and neuroimaging features of the PSP-CBD continuum
JL Whitwell - Current opinion in neurology, 2023 - ncbi.nlm.nih.gov
The findings help improve the imaging-based diagnosis of PSP and CBD, allow more
targeted prognostic estimates for patients accounting for phenotype or pathology, and will …
targeted prognostic estimates for patients accounting for phenotype or pathology, and will …